MCSPMLTEF
HALO icon

Metatron Capital SICAV plc - Metatron Long Term Equity Fund’s Halozyme HALO Stock Holding History

Metatron Capital SICAV plc - Metatron Long Term Equity Fund’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Buy
+34,000
New +$2.32M 1.21% 25

Other funds holding HALO

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MMC
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Metatron Capital SICAV plc - Metatron Long Term Equity Fund's HALO Position: Q2 2026 in Review

Metatron Capital SICAV plc - Metatron Long Term Equity Fund opened a new position in Halozyme (HALO) in Q2 2026: 34,000 shares worth $2.66M. The stake represents 1.21% of the portfolio and ranks #25 among its holdings.

207 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Metatron Capital SICAV plc - Metatron Long Term Equity Fund held 34,000 shares of Halozyme worth $2.66M as of Q2 2026.
  • Halozyme was a new Metatron Capital SICAV plc - Metatron Long Term Equity Fund position in Q2 2026.
  • Halozyme made up 1.21% of Metatron Capital SICAV plc - Metatron Long Term Equity Fund's portfolio in Q2 2026, its #25 holding.
  • 207 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Metatron Capital SICAV plc - Metatron Long Term Equity Fund's 13F filing for Q2 2026, filed 29 Jul 2026.